Calyxt

Calyxt, Inc. is technology company. engages in delivering plant-based solutions. Its products include high oleic soybean oil, high fiber wheat, high oleic soybean meal, and low lignin alfalfa. The company was founded by Daniel F. Voytas and André Choulika on January 8, 2010 and is headquartered in Roseville, MN.

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. It focuses on using gene editing to develop productivity traits in major agricultural crops such as Canola, Rice, Soybean, Corn and Wheat. The company was founded by Rory Riggs, Peter Beetham and Greg Gocal in 2010 and is headquartered in San Diego, CA.

Calyxt, Inc. (CLXT) CEO Jim Blome on Q2 2019 Results - Earnings Call Transcript

Calyxt (CLXT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Calyxt (CLXT) Expected to Beat Earnings Estimates: Should You Buy?

Calyxt has now commercialized two products from its high-oleic soybean platform and sales should start ramping this year.

Calyxt Continues To Make More Progress Than Is Shown In The Share Price

Calyxt, Inc. (CLXT) CEO Jim Blome on Q1 2019 Results - Earnings Call Transcript

Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Calyxt (CLXT) Q1 Earnings Expected to Decline

Calyxt (CLXT) delivered earnings and revenue surprises of -4.00% and -99.83%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Calyxt (CLXT) Reports Q4 Loss, Lags Revenue Estimates

News for Calyxt Stock (CLXT)